← Browse by Condition
Medical Condition
clear cell renal cell carcinoma
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for clear cell renal cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — clear cell renal cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for clear cell renal cell carcinoma?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for clear cell renal cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for clear cell renal cell carcinoma?
clear cell renal cell carcinoma research spans Phase 1 (4 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a clear cell renal cell carcinoma clinical trial?
Eligibility criteria for clear cell renal cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07389629 Phase 2
Recruiting
Enrollment
25 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05086692 Phase 1, Phase 2
Recruiting
Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
NCT05536141 Phase 1
Recruiting
Enrollment
362 pts
Location
United States, Austr...
Sponsor
Arcus Biosciences, Inc.
NCT07688187 Phase 1
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
PeptiDream Inc.
NCT07223541 Phase 2
Recruiting
Enrollment
72 pts
Location
United States
Sponsor
University of Oklahoma
NCT05433142 Phase 1
Recruiting
Enrollment
307 pts
Location
United States, Belgi...
Sponsor
Xencor, Inc.
NCT06088134
Recruiting
Enrollment
800 pts
Location
China
Sponsor
Mingzhao Xiao
Related Conditions
iparomlimab and tuvonralimab (1) neoadjuvant therapy (1) advanced solid tumor (1) unresectable solid tumor (1) triple negative breast cancer (1) non small cell lung cancer squamous (1) non small cell lung cancer non squamous (1) colorectal cancer msi h (1) gastric cancer (1) cervical cancer (1) basal cell carcinoma (1) bladder cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology